Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-28

Clinical Trial Update: Simulated Driving Study in Restless Legs Syndrome [Phase 2]

View source ↗

Summary

Results from a Phase 2 simulated driving study in Restless Legs Syndrome sponsored by XenoPort have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: XenoPort, Inc. | Conditions: Restless Legs Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2011-06-28